1. |
Widmer LK, Stfihelin HB, NissenC, et al. Prospektiv-epidemiologische Untersuchung, Basler Studie Ⅰ-Ⅲ 1959-1978[M]. Bern Stuttgart Wien, Hans Huber, 1981:10-17.
|
2. |
Unno N, Mitsuoka H, Uchiyama T, et al. Superficial thrombophlebitis of the lower limbs in patients with varicose veins[J]. Surg Today, 2002, 32(5):397-401.
|
3. |
Decousus H, Epinat M, Guillot K, et al. Superficial vein thrombosis:risk factors, diagnosis, and treatment[J]. Curr Opin Pulm Med, 2003, 9(5): 393-397.
|
4. |
Beatty J, Fitridge R, Benveniste G, et al. Acute superficialvenous thrombophlebitis:does emergency surgery have a role?[J]. Int Angiol, 2002, 21(1):93-95.
|
5. |
Superficial Thrombophlebitis Treated By Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis[J]. Arch Intern Med, 2003, 163(14):1657-1663.
|
6. |
Sobreira ML, Yoshida WB, Lastoria. Superficial thrombophlebitis:epidemiology, physiopathology, diagnosis and treatment[J]. J Vasc Bras, 2008, 7(2):131-143.
|
7. |
Segal JB, Brotman DJ, Necochea AJ, et al. Predictive value of factorⅤLeiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation:a systematic review[J]. JAMA, 2009, 301(23):2472-2485.
|
8. |
Martinelli I, Battaglioli T, Razzari C, et al. Type and location of venous thromboembolism in patients with factorⅤ Leiden or prothrombin G20210A and in those with no thrombophilia[J]. J Thromb Haemost, 2007, 5(1):98-101.
|
9. |
Schönauer V, Kyrle PA, Weltermann A, et al. Superficial thrombophlebitis and risk for recurrent venous thromboembolism[J]. J Vasc Surg, 2003, 37(4):834-838.
|
10. |
Kovac M, Mitic G, Mikovic Z, et al. Type and location ofvenous thromboembolism in carriers of FactorⅤLeiden or prothrombin G20210A mutation versus patients with no mutation[J]. Clin Appl Thromb Hemost, 2010, 16(1):66-70.
|
11. |
Middeldorp S. Evidence-based approach to thrombophilia testing[J]. J Thromb Thrombolysis, 2011, 31(3):275-281.
|
12. |
Leong DP, Dundon BK, Worthley MI. Trousseau’s syndrome[J]. Intern Med J, 2011, 41(3):289.
|
13. |
Kondo T. Traumatic funicular phlebitis of the thoracic wallresembling Mondor’s disease:a case report[J]. J Med Case Rep, 2011, 5:127.
|
14. |
Kahn JB, Baharestani S, Beck HC, et al. Orbital dissemination of Lemierre syndrome from gram-positive septic emboli[J]. Ophthal Plast Reconstr Surg, 2011, 27(3):e67-e68.
|
15. |
Fazeli B, Modaghegh H, Ravrai H, et al. Thrombophlebitis migrans as a footprint of Buerger’s disease:a prospective-descriptive study in north-east of Iran[J]. Clin Rheumatol, 2008, 27(1):55-57.
|
16. |
Decousus H, Quéré I, Presles E, et al. Superficial venous thrombosis and venous thromboembolism:a large, prospective epidemiologic study[J]. Ann Intern Med, 2010, 152(4):218-224.
|
17. |
Milio G, Siragusa S, Minà C, et al. Superficial venous thrombosis:prevalence of common genetic risk factors and their role on spreading to deep veins [J]. Thromb Res, 2008, 123(2):194-199.
|
18. |
梁勇, 金星. 下肢血栓性浅静脉炎并发肺栓塞[J]. 中国普通外科杂志, 2006, 15(1):23-75.
|
19. |
Kitchens CS. How I treat superficial venous thrombosis[J]. Blood, 2011, 117(1):39-44.
|
20. |
Cesarone MR, Belcaro G, Agus G, et al. Management of superficial vein thrombosis and thrombophlebitis:status and expert opinion document[J]. Angiology, 2007, 58 Suppl 1:7S-15S.
|
21. |
van Weert H, Dolan G, Wichers I, et al. Spontaneous superficial venous thrombophlebitis:does it increase risk for thromboembolism? A historic follow-up study in primary care[J]. J Fam Pract, 2006, 55(1):52-57.
|
22. |
Prandoni P, Tormene D, Pesavento R;Vesalio Investigators Group. High vs. low doses of low-molecular-weight heparin for the treatment of superficial vein thrombosis of the legs:a double-blind, randomized trial[J]. J Thromb Haemost, 2005, 3(6):1152-1157.
|
23. |
Marchiori A, Verlato F, Sabbion P, et al. High versus low doses of unfractionated heparin for the treatment of superficial thrombophlebitis of the leg. A prospective, controlled, randomized study[J]. Haematologica, 2002, , 87(5):523-527.
|
24. |
Kearon C,Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest, 2008, 133(6 Suppl):454S-545S.
|
25. |
Decousus H, Prandoni P, Mismetti P, et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs[J]. N Engl J Med, 2010, 363(13):1222-1232.
|
26. |
Lee JT, Kalani MA. Treating superficial venous thrombophlebitis[J]. J Natl Compr Canc Netw, 2008, 6(8):760-765.
|
27. |
Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis:a prospective study[J]. Vasc Endovascular Surg, 2003, 37(6):415-420.
|
28. |
王霆. 刺血拔罐治疗血栓性浅静脉炎[J]. 中国针灸, 2011, 31(1):22.
|